A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...

They disable our defenses and hijack the cellular machinery in order to multiply successfully. For example, the herpes simplex virus 1, which causes blister-like skin rashes, and influenza viruses ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based ...

This technical note explores a novel poly(A) tail modification that enhances total protein expression and extends expression ...

This culminated in a $500m funding cut to mRNA vaccine research funding, impacting around 22 projects being run at the ...

Recently, demands in RNA manufacturing for long-chain RNAs exceeding 100 nucleotides, such as single guide RNA (sgRNA) for genome editing, have been increasing. Generally, these types of RNA are ...

The final, formatted version of the article will be published soon. Background: Atrial fibrosis serves as a key pathological basis for atrial fibrillation, significantly elevating the risk of ...

While AMT-130 could result in meaningful revenue for ClearPoint, the Huntington's opportunity is relatively modest compared to some of ClearPoint's other partner programs selected for expedited review ...